Intracellular delivery of the p38 mitogen-activated protein kinase inhibitor SB202190 [4-(4-Fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)1H- imidazole] in renal tubular cells: A novel strategy to treat renal fibrosis

Jai Prakash, Maria Sandovici, Vinay Saluja, Marie Lacombe, Roel Q.J. Schaapveld, Martin H. De Borst, Harry Van Goor, Robert H. Henning, Johannes H. Proost, Frits Moolenaar, György Kéri, Dirk K.F. Meijer, Klaas Poelstra, Robbert J. Kok*

*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

63 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Intracellular delivery of the p38 mitogen-activated protein kinase inhibitor SB202190 [4-(4-Fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)1H- imidazole] in renal tubular cells: A novel strategy to treat renal fibrosis'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science